Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidants for IVF in Poor Responders
NCT03085030Phase 4Completed
- Sponsor
- Cairo University
- Start
- Apr 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in female infertility (2 arms), sponsored by Cairo University. Primary endpoint: Pregnancy rate at 2 weeks. Started Apr 2017; status: completed.
02
Conditions
female infertility
Beyond the preview
Go deeper on NCT03085030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085030.